Xing Li, Hao Chen, Hongtai Duan, Qiong Ye, Jie Wang, Haibiao Wang, Kaijie Qiu
{"title":"Application of an innovative embedded parallel pancreaticojejunostomy technique in laparoscopic pancreaticoduodenectomy.","authors":"Xing Li, Hao Chen, Hongtai Duan, Qiong Ye, Jie Wang, Haibiao Wang, Kaijie Qiu","doi":"10.1186/s12957-026-04471-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical value of an innovative embedded parallel pancreaticojejunostomy technique for laparoscopic pancreaticoduodenectomy.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical data of 108 patients who underwent successful laparoscopic pancreaticoduodenectomy at The Affiliated Lihuili Hospital of Ningbo University, from January 2016 to July 2025. Patients were divided according to the type of pancreaticojejunostomy: the experimental group (n = 57) underwent an embedded parallel pancreaticojejunostomy, while the control group (n = 51) underwent duct-to-mucosa pancreaticojejunostomy. The baseline characteristics, tumor features, intraoperative and postoperative conditions, and complications were compared between the two groups. And through a multivariate logistic regression model, the independent effects of the surgical groups (experimental group, control group) were evaluated.</p><p><strong>Results: </strong>The incidence of grade B/C postoperative pancreatic fistula in the experimental group (5.3%) was significantly lower than that of the control group (19.6%), and the difference was statistically significant (P < 0.05). The pancreaticojejunostomy time (21.33 ± 2.73 min), postoperative drainage tube removal time (14.00, 10.00-17.50 days), and postoperative hospitalization (16.00, 12.50-21.00 days) in the experimental group were all significantly shorter than those in the control group (31.43 ± 2.30 min; 17.00, 11.00-28.00 days; 20.00, 13.00-29.00 days, respectively; all P < 0.05). There were no significant differences (P > 0.05) between the two groups in age, American Society of Anesthesiologists, Fistula Risk Score, main pancreatic duct diameter, sex, body mass index, pathological type, maximal tumor diameter, pancreatic texture, intraoperative margin status, lymph node metastasis, operative time, intraoperative blood loss, delayed gastric emptying, or postoperative bleeding. And the intervention measure (experimental group, control group) was independent protective factors for reducing postoperative pancreatic fistula (OR=0.19, 95% Cl, 0.05-0.75, P < 0.05).</p><p><strong>Conclusion: </strong>The embedded parallel pancreaticojejunostomy technique can effectively reduce the incidence of postoperative pancreatic fistula and shorten pancreaticojejunostomy time. This technique is a simple and effective new method for pancreaticojejunostomy and is worthy of application in laparoscopic pancreaticoduodenectomy.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13576356/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12957-026-04471-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To investigate the clinical value of an innovative embedded parallel pancreaticojejunostomy technique for laparoscopic pancreaticoduodenectomy.
Methods: We retrospectively analyzed the clinical data of 108 patients who underwent successful laparoscopic pancreaticoduodenectomy at The Affiliated Lihuili Hospital of Ningbo University, from January 2016 to July 2025. Patients were divided according to the type of pancreaticojejunostomy: the experimental group (n = 57) underwent an embedded parallel pancreaticojejunostomy, while the control group (n = 51) underwent duct-to-mucosa pancreaticojejunostomy. The baseline characteristics, tumor features, intraoperative and postoperative conditions, and complications were compared between the two groups. And through a multivariate logistic regression model, the independent effects of the surgical groups (experimental group, control group) were evaluated.
Results: The incidence of grade B/C postoperative pancreatic fistula in the experimental group (5.3%) was significantly lower than that of the control group (19.6%), and the difference was statistically significant (P < 0.05). The pancreaticojejunostomy time (21.33 ± 2.73 min), postoperative drainage tube removal time (14.00, 10.00-17.50 days), and postoperative hospitalization (16.00, 12.50-21.00 days) in the experimental group were all significantly shorter than those in the control group (31.43 ± 2.30 min; 17.00, 11.00-28.00 days; 20.00, 13.00-29.00 days, respectively; all P < 0.05). There were no significant differences (P > 0.05) between the two groups in age, American Society of Anesthesiologists, Fistula Risk Score, main pancreatic duct diameter, sex, body mass index, pathological type, maximal tumor diameter, pancreatic texture, intraoperative margin status, lymph node metastasis, operative time, intraoperative blood loss, delayed gastric emptying, or postoperative bleeding. And the intervention measure (experimental group, control group) was independent protective factors for reducing postoperative pancreatic fistula (OR=0.19, 95% Cl, 0.05-0.75, P < 0.05).
Conclusion: The embedded parallel pancreaticojejunostomy technique can effectively reduce the incidence of postoperative pancreatic fistula and shorten pancreaticojejunostomy time. This technique is a simple and effective new method for pancreaticojejunostomy and is worthy of application in laparoscopic pancreaticoduodenectomy.
期刊介绍:
World Journal of Surgical Oncology publishes articles related to surgical oncology and its allied subjects, such as epidemiology, cancer research, biomarkers, prevention, pathology, radiology, cancer treatment, clinical trials, multimodality treatment and molecular biology. Emphasis is placed on original research articles. The journal also publishes significant clinical case reports, as well as balanced and timely reviews on selected topics.
Oncology is a multidisciplinary super-speciality of which surgical oncology forms an integral component, especially with solid tumors. Surgical oncologists around the world are involved in research extending from detecting the mechanisms underlying the causation of cancer, to its treatment and prevention. The role of a surgical oncologist extends across the whole continuum of care. With continued developments in diagnosis and treatment, the role of a surgical oncologist is ever-changing. Hence, World Journal of Surgical Oncology aims to keep readers abreast with latest developments that will ultimately influence the work of surgical oncologists.